Trial Profile
Effects of ticagrelor vs prasugrel on platelet reactivity in diabetic patients with acute coronary syndromes undergoing PCI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Mar 2014
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 30 Mar 2014 New trial record